Patent Assignment
Reel/Frame 042832/0269
Change of Name
Recorded: 2017-06-15
Pages: 4
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2015-12-18
Assignee
IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties
(10)
Compositions and Methods For Optimizing Cleavage of RNA By Rnase H
Chimeric Oligomeric Compounds Comprising Alternating Regions of Northern and Southern Conformational Geometry
Oligomeric Compounds Comprising Bicyclic Nucleosides and Having Reduced Toxicity
5' and 2' Bis-Substituted Nucleosides and Oligomeric Compounds Prepared Therefrom
Modulation of Signal Transducer and Activator of Transcription 3 (STAT3)Expression
Compositions and Methods for Modulation of Lmna Expression
Antisense Modulation of Gcgr Expression
Substituted 2'-Amino and 2'-Thio-Bicyclic Nucleosides and Oligomeric Compounds Prepared Therefrom
Tetrahydropyran Nucleic Acid Analogs
Antisense Modulation of Kinesin-Like 1 Expression
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 26, 2012
From: SWAYZE, ERIC E.; FREIER, SUSAN M.; MACLEOD, ROBERT A.; KIM, YOUNGSOO
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 028111/0479 →
Assignment of Assignor's Interest
Nov 14, 2012
From: FREIER, SUSAN M.; BHANOT, SANJAY
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 029295/0178 →
Assignment of Assignor's Interest
Aug 15, 2013
From: JAIN, RAVI
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 031020/0761 →